Center for Scientific Review; Notice of Closed Meeting, 75466 [2015-30519]
Download as PDF
<![CDATA[
75466
Federal Register / Vol. 80, No. 231 / Wednesday, December 2, 2015 / Notices
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dr. Dale P. Sandler,
Chief, Epidemiology Branch, NIEHS,
Rall Building A3–05, P.O. Box 12233,
Research Triangle Park, NC 27709, or
call non-toll free number (919) 541–
4668 or email your request, including
your address to: sandler@niehs.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: The Sister
Study: A Prospective Study of the
Genetic and Environmental Risk Factors
for Breast Cancer, Revision OMB #0925–
0522 Expiration Date: 2/29/2016,
National Institute of Environmental
Health Sciences (NIEHS), the National
Institutes of Health (NIH).
Need and Use of Information
Collection: This is to continue the longterm follow-up of the Sister Study—a
study of genetic and environmental risk
factors for the development of breast
cancer in a high-risk cohort of sisters of
women who have had breast cancer.
The etiology of breast cancer is
complex, with both genetic and
environmental factors likely playing a
role. Environmental risk factors,
however, have been difficult to identify.
By focusing on genetically susceptible
Estimated
annual number
of respondents
Activity
Annual Update .................................................................................................
Follow-Up III (triennial) .....................................................................................
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
16,108.
Dated: November 23, 2015.
Laurie K. Johnson,
Acting Deputy Associate Director for
Management, NIEHS.
[FR Doc. 2015–30527 Filed 12–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jstallworth on DSK7TPTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Sep<11>2014
13:24 Dec 01, 2015
Jkt 238001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics on Pregnancy and
Neonatology.
Date: December 21, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
MSC 7890, Bethesda, MD 20892, 301 435–
2514, riverase@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Frm 00016
Fmt 4703
Sfmt 4703
Number of
reponses per
respondent
32,215
16,108
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
subgroups, more precise estimates of the
contribution of environmental and other
non-genetic factors to disease risk may
be possible. Sisters of women with
breast cancer are one group at increased
risk for breast cancer; we would expect
at least 2 times as many breast cancers
to accrue in a cohort of sisters as would
accrue in a cohort identified through
random sampling or other means. In
addition, a cohort of sisters should be
enriched with regard to the prevalence
of relevant genes and/or exposures,
further enhancing the ability to detect
gene-environment interactions. Sisters
of women with breast cancer will also
be at increased risk for ovarian cancer
and possibly for other hormonallymediated diseases. From August 2003
through July 2009, we enrolled a cohort
of 50,884 women who had not had
breast cancer. We estimated that after
the cohort was fully enrolled,
approximately 300 new cases of breast
cancer will be diagnosed during each
year of follow-up. Thus far 2,904
participants have reported being
diagnosed with breast cancer.
Average
burden per
response
(in hours)
1
1
Total burden
hours per year
10/60
40/60
5,369
10,739
Dated: November 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–30519 Filed 12–1–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\02DEN1.SGM
02DEN1
]]>Agencies
[Federal Register Volume 80, Number 231 (Wednesday, December 2, 2015)]
[Notices]
[Page 75466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-30519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics on Pregnancy and Neonatology.
Date: December 21, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200, MSC 7890, Bethesda, MD
20892, 301 435-2514, riverase@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: November 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-30519 Filed 12-1-15; 8:45 am]
BILLING CODE 4140-01-P
